Testing effectiveness (Phase 2)UnknownNCT01246817What this trial is testingTemsirolimus-RCC-imagingWho this might be right forRenal Cell Cancer Radboud University Medical Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT04322318What this trial is testingCombination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTWho this might be right forAnaplastic Kidney Wilms TumorRecurrent Kidney Wilms TumorStage II Kidney Wilms Tumor+2 more Children's Oncology Group 256
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07405086What this trial is testingMorning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyWho this might be right forAdvanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Study completedNCT00060307What this trial is testingErlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell CancerWho this might be right forRecurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT05935748What this trial is testingPh2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)Who this might be right forccRCCClear Cell Renal Cell CarcinomaKidney Cancer+18 more NiKang Therapeutics, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT01034878What this trial is testingSunitinib in Metastatic Renal CancerWho this might be right forCarcinoma, Renal Cell Istituto Clinico Humanitas 25
Testing effectiveness (Phase 2)Study completedNCT01693822What this trial is testingA Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for NephrectomyWho this might be right forClear-cell Metastatic Renal Cell Carcinoma Institute of Cancer Research, United Kingdom 65
Large-scale testing (Phase 3)Active Not RecruitingNCT00352534What this trial is testingVincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' TumorWho this might be right forStage I Kidney Wilms TumorStage II Kidney Wilms TumorStage III Kidney Wilms Tumor Children's Oncology Group 808
Not applicableLooking for participantsNCT00050752What this trial is testingHereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal CancerWho this might be right forRenal Tumor HistologyCutaneous LeiomyomaKidney Cancer National Cancer Institute (NCI) 1,130
Early research (Phase 1)Study completedNCT01005797What this trial is testingStudy of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung CancersWho this might be right forRenal CancerNon Small Cell Lung Cancer (NSCLC)Soft Tissue Sarcoma Medical University of South Carolina 38
Testing effectiveness (Phase 2)Study completedNCT00923481What this trial is testingA Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...Who this might be right forHead and Neck NeoplasmsPheochromocytomaColorectal Neoplasms+2 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Not applicableUnknownNCT05534854What this trial is testingFrequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer SyndromesWho this might be right forRenal Tumor HistologyKidney CancerRenal Cell Carcinoma+11 more RenJi Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT05756569What this trial is testingEnfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant HistologyWho this might be right forBladder Squamous Cell CarcinomaLocally Advanced Bladder CarcinomaMalignant Renal Pelvis Neoplasm+8 more Emory University 25
Not applicableEnded earlyNCT00491621What this trial is testingEvaluation of Diagnostic Value of Molecular Markers in Renal CancerWho this might be right forKidney Neoplasms Centre Hospitalier Universitaire de Saint Etienne 74
Large-scale testing (Phase 3)Looking for participantsNCT06401330What this trial is testingA Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)Who this might be right forStage I Mixed Cell Type Kidney Wilms TumorStage II Mixed Cell Type Kidney Wilms TumorStage III Mixed Cell Type Kidney Wilms Tumor+1 more Children's Oncology Group 1,656
Testing effectiveness (Phase 2)Study completedNCT01399918What this trial is testingEverolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)Who this might be right forRenal Cell Carcinoma Memorial Sloan Kettering Cancer Center 57
Large-scale testing (Phase 3)Active Not RecruitingNCT00379340What this trial is testingCombination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' TumorWho this might be right forStage III Kidney Wilms TumorStage IV Kidney Wilms Tumor Children's Oncology Group 395
Testing effectiveness (Phase 2)Active Not RecruitingNCT03541902What this trial is testingCabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell CarcinomaWho this might be right forMalignant Neoplasms of Urinary TractRenal Cell CarcinomaChromophobe Renal Cell Carcinoma+6 more M.D. Anderson Cancer Center 32
Early research (Phase 1)Study completedNCT01672775What this trial is testingAssess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary HistologyWho this might be right forCarcinoma, Renal CellRenal Cell Carcinoma of Papillary HistologyRenal Cell Carcinoma With Clear Cell Histology+1 more Agensys, Inc. 34